No Data
The commercialization of the product is difficult to support alone, and has the identity of the largest bearish event within the year for Science and Economy Pharmaceutical (02171) through the Hong Kong Stock Connect program?
For SciClone Pharmaceuticals-B (02171), the most important milestone event in 2024 is the successful commercialization of the core variety CT053 in March this year. However, the commercialization of the first product did not bring further valuation leap on the secondary market to the company, instead it led to a continuously declining stock price.
CARSGEN-B: INTERIM REPORT 2024
Koji Pharmaceutical - B (02171) fell by 59.60%, now reported at 2.69 yuan, hitting a 52-week low.
As of 11:46, Keji Pharmaceutical - B (02171) fell 59.60% compared to the previous closing price, now at 2.690 yuan, hitting a 52-week low; volume of 3.6526 million shares, with a turnover of 9.8273 million Hong Kong dollars.
CARsgen Therapeutics Holdings Limited's (HKG:2171) Stock Price Dropped 26% Last Week; Individual Investors Would Not Be Happy
CARsgen Announces 2024 Interim Results
CARsgen Therapeutics Holdings Books Narrower Attributable Loss in H1
Insiders Could Have Profited By Holding Onto CARsgen Therapeutics Holdings Shares Despite 23% DropNo Data
No Data
